Estimating sodium intake from spot urine samples at population level: a validation and application study in French adults.


Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
28 07 2019
Historique:
pubmed: 23 4 2019
medline: 8 5 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

The aim of this study was to assess the validity of the predictive INTERSALT equation using spot urine samples to estimate 24-h urinary Na (24-hUNa) excretion and daily Na intake among the French adult population. Among 193 French adults ('validation sample'), we assessed the validity by comparing predicted 24-hUNa excretion from spot urine and measured 24-hUNa excretion from 24-h urine collections. Spearman correlation coefficients and Bland-Altman plots were used and we calculated calibration coefficients. In a nationally representative sample of 1720 French adults ('application sample'), the calibrated predictive equation was then applied to the spot urine Na values to estimate 24-hUNa excretion and daily Na intake. In that sample, predicted Na intake was compared with that estimated from 24-h dietary recalls. Results were adjusted and corrected using calibration coefficients. In the validation sample, the measured 24-hUNa excretion was on average 14 % higher than the predicted 24-hUNa (+13 % for men and +16 % for women). Correlation between measured and predicted 24-hUNa excretion was moderate (Spearman r 0·42), and the Bland-Altman plots showed underestimation at lower excretion level and overestimation at higher level. In the application study, estimated daily salt intake was 8·0 g/d using dietary recalls, 8·1 g/d using predicted INTERSALT equation and 9·3 g/d after applying calibration coefficients calculated in the validation study. Despite overall underestimation of 24-hUNa excretion by spot urinary Na, the use of predictive INTERSALT equation remains an acceptable alternative in monitoring global Na intake/excreted in the French population but its use is not advised at the individual level.

Identifiants

pubmed: 31006386
pii: S0007114519000886
doi: 10.1017/S0007114519000886
doi:

Substances chimiques

Sodium, Dietary 0
Sodium 9NEZ333N27

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-194

Auteurs

Elise Emeville (E)

Observatoire de la Santé de Guadeloupe (ORSaG), Baie-Mahault, France.

Camille Lassale (C)

Department of Epidemiology and Public Health, University College London, London WC1E 7HB, UK.
Program of Epidemiology and Public Health, Hospital del Mar Medical Research Institute (IMIM), 08024 Barcelona, Spain.

Katia Castetbon (K)

Université libre de Bruxelles, Ecole de Santé Publique, Centre de Recherche en Epidémiologie, Biostatistique, et Recherche Clinique, B-1070 Bruxelles, Belgium.

Valérie Deschamps (V)

Nutrition Surveillance and Epidemiology Team, Santé publique France, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.

Benoît Salanave (B)

Nutrition Surveillance and Epidemiology Team, Santé publique France, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.

Michel Vernay (M)

Santé publique France, Regions Division, Saint-Maurice, France.

Dorra Guergour (D)

Platform of Biochemistry, University Hospital of Grenoble, Grenoble F-38700, France.

Patrice Faure (P)

Platform of Biochemistry, University Hospital of Grenoble, Grenoble F-38700, France.
University Grenoble Alpes, HP2 Laboratory, Grenoble F-38058, France.

Serge Hercberg (S)

Nutrition Surveillance and Epidemiology Team, Santé publique France, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.
Nutritional Epidemiology Research Team, INSERM U1153, INRA U1125, CNAM, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.
Public Health Department, Avicenne Hospital, University Paris 13, Bobigny F-93017, France.

Pilar Galan (P)

Nutritional Epidemiology Research Team, INSERM U1153, INRA U1125, CNAM, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.

Emmanuelle Kesse-Guyot (E)

Nutritional Epidemiology Research Team, INSERM U1153, INRA U1125, CNAM, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.

Charlotte Verdot (C)

Nutrition Surveillance and Epidemiology Team, Santé publique France, University Paris 13, Centre of Research in Epidemiology and StatisticS (CRESS UMR1153) - University of Paris, Bobigny F-93017, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH